PsychedelicNewsWire is a financial news company with a new approach to aggregation and syndication.
27/06/2025
$NRXP Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100 https://ibn.fm/IznWK
24/06/2025
PsychedelicNewsBreaks – $NRXP Taps IBN to Lead Corporate Communications Amid Drug Advancements and Subsidiary Launch https://ibn.fm/LOLSX
12/06/2025
$NRXP Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100 Amid Ongoing Shortage https://ibn.fm/ji1Ro
05/06/2025
$NRXP Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network https://ibn.fm/y0R4H
03/06/2025
PsychedelicNewsBreaks – Rythmia Life Advancement Center Unveils Affiliate Program for Wellness Advocates https://ibn.fm/59Zl6
28/05/2025
$NRXP Announces $10.3 Million Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval https://ibn.fm/73Ru2
23/05/2025
$NRXP Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition https://ibn.fm/NjjoU
23/05/2024
4th Annual Psychedelic Therapeutics and Drug Development Conference Comes to Boston, MA https://ibn.fm/Gk4SC
16/05/2024
PsychedelicNewsBreaks – 4th Annual Psychedelic Therapeutics and Drug Development Conference to Bridge Gaps in Research and Development of Therapeutic Psychedelics https://ibn.fm/VbpiL
19/02/2024
Happy Presidents Day from IBN!
25/12/2023
Happy Holidays from everyone at IBN! 🎄
19/12/2023
DEA Renews Efforts to Ban Psychedelics Despite Backlash in 2022 https://ibn.fm/x8QA7
Be the first to know and let us send you an email when Psychedelic News Wire posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.